National Registry and Blood Bank of Patients With Liver Cancer
NCT00482365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 151
Last updated 2013-08-19
Summary
RATIONALE: Gathering health information about patients with liver cancer over time may help doctors learn more about the disease and may help the study of cancer in the future.
PURPOSE: This clinical trial is developing a national registry and blood bank of patients with liver cancer.
Conditions
Interventions
- OTHER
-
biologic sample preservation procedure
biologic sample preservation procedure
- OTHER
-
medical chart review
review of patients' medical records at study entry and every 6 months
- OTHER
-
Patient interview
Elicit demographic data as well as information about personal habits such as drinking and smoking.
Sponsors & Collaborators
-
Vanderbilt-Ingram Cancer Center
lead OTHER
Principal Investigators
-
Sunil Geevarghese, MD · Vanderbilt-Ingram Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-04-30
- Primary Completion
- 2009-04-30
- Completion
- 2009-08-31
Countries
- United States
Study Locations
More Related Trials
-
Navigating the Clinical Trial Process for Hepatocellular Carcinoma
NCT05859945 ·Status: NOT_YET_RECRUITING
-
Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome
NCT01494324 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
NCT00913757 ·Status: COMPLETED
-
A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer
NCT05660213 ·Status: NOT_YET_RECRUITING
-
Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment
NCT04143516 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery
NCT00469963 ·Status: TERMINATED ·Phase: NA
-
Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid
NCT06699524 ·Status: ACTIVE_NOT_RECRUITING
-
Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT02507765 ·Status: COMPLETED ·Phase: PHASE1
-
Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
NCT01525069 ·Status: TERMINATED ·Phase: PHASE1
-
Advanced Therapies for Liver Metastases
NCT04622423 ·Status: RECRUITING
-
Liver Cancer Registry Platform
NCT04510740 ·Status: RECRUITING
-
Quality Of Life in Patients With Malignant Biliary Obstruction
NCT00579865 ·Status: COMPLETED
-
Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer
NCT04656249 ·Status: COMPLETED ·Phase: PHASE2
-
Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer
NCT01042041 ·Status: COMPLETED ·Phase: PHASE1
-
The Utility of Cell-free DNA Methylation Markers for Hepatocellular Carcinoma
NCT05573217 ·Status: UNKNOWN
-
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
NCT01668134 ·Status: COMPLETED ·Phase: PHASE1
-
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
NCT04145141 ·Status: ACTIVE_NOT_RECRUITING
-
Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer
NCT01126645 ·Status: COMPLETED ·Phase: PHASE2
-
Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.
NCT01256125 ·Status: UNKNOWN
-
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms
NCT01640522 ·Status: COMPLETED ·Phase: NA
-
Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
NCT05184400 ·Status: RECRUITING
-
MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma
NCT02575339 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
NCT00986661 ·Status: UNKNOWN ·Phase: PHASE1
-
Combination of TATE and PD-1 Inhibitor in Liver Cancer
NCT03259867 ·Status: RECRUITING ·Phase: PHASE2
-
Recurrent Liver Cancer: Reconceptualization and Reevaluation
NCT06430983 ·Status: RECRUITING